使用修正样本量公式与泊松-伽马受试者招募模型设计III期事件时间临床试验:采用PERT分布考虑中心启动延迟
针对多中心事件时间临床试验中样本量与受试者招募的先验估计难题,本文提出将PERT模型引入样本量估计以考虑中心启动延迟,并将PERT模型引入泊松-伽马受试者招募模型以预测所需研究中心数量。即使PERT分布输入设定有误,该模型相比所有中心同时启动的传统假设仅导致极小把握度损失,为考虑灵活中心启动流程的多中心事件时间临床试验设计提供了改进方法。
要点
- 将PERT模型引入样本量估计,可考虑中心启动延迟对观测随访时间的影响。
- 将PERT模型引入泊松-伽马受试者招募模型,可预测所需研究中心数量。
- 即使PERT分布输入设定有误,相比所有中心同时启动的传统假设仅导致极小把握度损失。
核心结论
- 所提出的修正样本量公式与泊松-伽马受试者招募模型为考虑灵活中心启动流程的多中心事件时间临床试验设计提供了改进方法。
研究设计与样本
- 方法学论文,提出将PERT模型引入样本量估计与泊松-伽马受试者招募模型,用于多中心事件时间临床试验的先验把握度评估与中心数量规划。
主要发现
- 将PERT模型引入样本量估计可考虑中心启动延迟,引入泊松-伽马受试者招募模型可预测所需研究中心数量。
- 即使PERT分布输入设定有误,该模型相比所有中心同时启动的传统假设仅导致极小把握度损失。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A priori estimation of sample size and subject accrual in multi-site, time-to-event clinical trials is often challenging. Such trials are powered based on the number of events needed to detect a clinically significant difference. Sample size based on number of events relates to the expected duration of observation time for each subject. Temporal patterns in site initiation and subject enrollment ultimately affect when subjects can be accrued into the study. Lag times are common as the site start-up process optimizes, resulting in delays that may curtail observational follow-up and therefore undermine power. The proposed method introduces a Program Evaluation and Review Technique (PERT) model into the sample size estimation which accounts for the lag in site start-up. Additionally, a PERT model is introduced into a Poisson-Gamma subject accrual model to predict the quantity of study sites needed. The introduction of the PERT model provides greater flexibility in both a priori power assessment and planning the number of sites, as it specifically allows for the inclusion of anticipated delays in site start-up time. This model results in minimal power loss even when PERT distribution inputs are misspecified compared to the traditional assumption of simultaneous start-up for all sites. Together these updated formulations for sample size and subject accrual models offer an improved method for designing a multi-site time-to-event clinical trial that accounts for a flexible site start-up process.
引用
- Shipes VB, Meinzer C, Wolf BJ, et al. Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution. Stat Med. 2023. PMID: 37926516. doi:10.1002/sim.9935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。